77 related articles for article (PubMed ID: 11435249)
1. Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma.
Orsida BE; Ward C; Li X; Bish R; Wilson JW; Thien F; Walters EH
Am J Respir Crit Care Med; 2001 Jul; 164(1):117-21. PubMed ID: 11435249
[TBL] [Abstract][Full Text] [Related]
2. An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma.
Li X; Ward C; Thien F; Bish R; Bamford T; Bao X; Bailey M; Wilson JW; Haydn Walters E
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1493-9. PubMed ID: 10556111
[TBL] [Abstract][Full Text] [Related]
3. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[TBL] [Abstract][Full Text] [Related]
4. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
5. The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma.
Malone R; LaForce C; Nimmagadda S; Schoaf L; House K; Ellsworth A; Dorinsky P
Ann Allergy Asthma Immunol; 2005 Jul; 95(1):66-71. PubMed ID: 16095144
[TBL] [Abstract][Full Text] [Related]
6. Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.
Jarjour NN; Wilson SJ; Koenig SM; Laviolette M; Moore WC; Davis WB; Doherty DE; Hamid Q; Israel E; Kavuru MS; Ramsdell JW; Tashkin DP; Reilly DS; Yancey SW; Edwards LD; Stauffer JL; Dorinsky PM; Djukanovic R
J Allergy Clin Immunol; 2006 Jul; 118(1):44-52. PubMed ID: 16815137
[TBL] [Abstract][Full Text] [Related]
7. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
[TBL] [Abstract][Full Text] [Related]
8. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.
Barnes NC; Qiu YS; Pavord ID; Parker D; Davis PA; Zhu J; Johnson M; Thomson NC; Jeffery PK;
Am J Respir Crit Care Med; 2006 Apr; 173(7):736-43. PubMed ID: 16424444
[TBL] [Abstract][Full Text] [Related]
9. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
Simons FE
N Engl J Med; 1997 Dec; 337(23):1659-65. PubMed ID: 9385125
[TBL] [Abstract][Full Text] [Related]
10. Vascularity in asthmatic airways: relation to inhaled steroid dose.
Orsida BE; Li X; Hickey B; Thien F; Wilson JW; Walters EH
Thorax; 1999 Apr; 54(4):289-95. PubMed ID: 10092688
[TBL] [Abstract][Full Text] [Related]
11. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
[TBL] [Abstract][Full Text] [Related]
12. Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo.
Reid DW; Ward C; Wang N; Zheng L; Bish R; Orsida B; Walters EH
Eur Respir J; 2003 Jun; 21(6):994-9. PubMed ID: 12797494
[TBL] [Abstract][Full Text] [Related]
13. Airway tissue mast cells in persistent asthma: predictor of treatment failure when patients discontinue inhaled corticosteroids.
Kraft M; Martin RJ; Lazarus SC; Fahy JV; Boushey HA; Lemanske RF; Szefler SJ;
Chest; 2003 Jul; 124(1):42-50. PubMed ID: 12853500
[TBL] [Abstract][Full Text] [Related]
14. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
15. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
16. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
17. Safety of salmeterol in the maintenance treatment of asthma.
Nathan RA; Seltzer JM; Kemp JP; Chervinsky P; Alexander WJ; Liddle R; Mills R
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):243-8. PubMed ID: 7552926
[TBL] [Abstract][Full Text] [Related]
18. Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma.
Snowise NG; Clements D; Ho SY; Follows RM
Curr Med Res Opin; 2013 Dec; 29(12):1663-74. PubMed ID: 24010736
[TBL] [Abstract][Full Text] [Related]
19. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids.
Boulet LP; Turcotte H; Laviolette M; Naud F; Bernier MC; Martel S; Chakir J
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1308-13. PubMed ID: 11029336
[TBL] [Abstract][Full Text] [Related]
20. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
Pearlman DS; Chervinsky P; LaForce C; Seltzer JM; Southern DL; Kemp JP; Dockhorn RJ; Grossman J; Liddle RF; Yancey SW
N Engl J Med; 1992 Nov; 327(20):1420-5. PubMed ID: 1357554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
